Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2011 1
2012 1
2013 2
2014 4
2015 3
2016 2
2017 3
2018 3
2020 2
2021 5
2022 2
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.
Ferreira E, Ferreira D, Relvas-Santos M, Freitas R, Soares J, Azevedo R, Afonso LP, Lima L, Santos B, Gonçalves M, Silva AMN, Santos LL, Peixoto A, Ferreira JA. Ferreira E, et al. Among authors: silva amn. Int J Mol Sci. 2024 Mar 19;25(6):3462. doi: 10.3390/ijms25063462. Int J Mol Sci. 2024. PMID: 38542435 Free PMC article.
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy.
Freitas R, Ferreira E, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Santos B, Gonçalves M, Quintas S, Peixoto A, Palmeira C, Silva AMN, Santos LL, Oliveira MJ, Sarmento B, Ferreira JA. Freitas R, et al. Among authors: silva amn. ACS Nano. 2024 Apr 9;18(14):10088-10103. doi: 10.1021/acsnano.3c12487. Epub 2024 Mar 27. ACS Nano. 2024. PMID: 38535625
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy.
Freitas R, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Ferreira E, Gaiteiro C, Soares J, Cotton S, Gonçalves M, Eiras M, Santos B, Palmeira C, Correia MP, Oliveira MJ, Sarmento B, Peixoto A, Santos LL, Silva AMN, Ferreira JA. Freitas R, et al. Among authors: silva amn. J Control Release. 2024 Mar;367:540-556. doi: 10.1016/j.jconrel.2024.01.065. Epub 2024 Feb 3. J Control Release. 2024. PMID: 38301927
Vanadium Compounds with Antidiabetic Potential.
Amaral LMPF, Moniz T, Silva AMN, Rangel M. Amaral LMPF, et al. Among authors: silva amn. Int J Mol Sci. 2023 Oct 27;24(21):15675. doi: 10.3390/ijms242115675. Int J Mol Sci. 2023. PMID: 37958659 Free PMC article. Review.
Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
Duarte TL, Lopes M, Oliveira M, Santos AG, Vasco C, Reis JP, Antunes AR, Gonçalves A, Chacim S, Oliveira C, Porto B, Teles MJ, Moreira AC, Silva AMN, Schwessinger R, Drakesmith H, Henrique R, Porto G, Duarte D. Duarte TL, et al. Among authors: silva amn. Leukemia. 2024 Jan;38(1):96-108. doi: 10.1038/s41375-023-02067-9. Epub 2023 Oct 19. Leukemia. 2024. PMID: 37857886
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Gaiteiro C, Soares J, Relvas-Santos M, Peixoto A, Ferreira D, Paulo P, Brandão A, Fernandes E, Azevedo R, Palmeira C, Freitas R, Miranda A, Osório H, Prieto J, Lima L, Silva AMN, Santos LL, Ferreira JA. Gaiteiro C, et al. Among authors: silva amn. Theranostics. 2022 Mar 28;12(7):3150-3177. doi: 10.7150/thno.67409. eCollection 2022. Theranostics. 2022. PMID: 35547758 Free PMC article.
The (Bio)Chemistry of Non-Transferrin-Bound Iron.
Silva AMN, Rangel M. Silva AMN, et al. Molecules. 2022 Mar 9;27(6):1784. doi: 10.3390/molecules27061784. Molecules. 2022. PMID: 35335148 Free PMC article. Review.
Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications.
Lopes M, Duarte TL, Teles MJ, Mosteo L, Chacim S, Aguiar E, Pereira-Reis J, Oliveira M, Silva AMN, Gonçalves N, Martins G, Kong IY, Zethoven M, Vervoort S, Martins S, Quintela M, Hawkins ED, Trigo F, Guimarães JT, Mariz JM, Porto G, Duarte D. Lopes M, et al. Among authors: silva amn. Blood Adv. 2021 Aug 24;5(16):3102-3112. doi: 10.1182/bloodadvances.2021004373. Blood Adv. 2021. PMID: 34402883 Free PMC article.
35 results